Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
The Oncologist|May 6, 2020
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease BurdenFilippo Pietrantonio, Fotios Loupakis, Giovanni Randon, et al.
NPJ Breast Cancer|December 13, 2025
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancerEmma Zattarin, Antonio Marra, Antonella Palazzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch SyndromeChristopher J Schwartz, Edaise M da Silva, Antonio Marra, et al.
Breast Cancer Research : BCR|May 14, 2025
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapyKonstantinos Venetis, Giulia Cursano, Roberta Scafetta, et al.
NPJ Breast Cancer|July 13, 2023
Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?Jing Yu, Edaise M da Silva, Hae-Sun La, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
The Lancet Regional Health. Europe|June 9, 2021
Pediatric admissions to emergency departments of North-Western Italy during COVID-19 pandemic: A retrospective observational studyIrene Raffaldi, Emanuele Castagno, Ilaria Fumi, et al.
Nature Communications|February 21, 2024
Converging and evolving immuno-genomic routes toward immune escape in breast cancerJuan Blanco-Heredia, Carla Anjos Souza, Juan L Trincado, et al.
Nature Genetics|May 16, 2025
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
Nature Communications|July 1, 2026
A deep learning framework for efficient pathology image analysisPeter Neidlinger, Tim Lenz, Sebastian Foersch, et al.
Pageof 11